Navigation Links
NFL Docs Urge More Caution With Key Pain Med
Date:9/11/2012

TUESDAY, Sept. 11 (HealthDay News) -- New recommendations by NFL team doctors suggest increased caution in the use of the pain reliever ketorolac tromethamine (Toradol) by professional football players.

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID). Athletes have long taken NSAIDs for pain prevention and relief before, during and after competition. But the recommendations by a task force developed through the NFL Team Physicians Society suggests more careful use of ketorolac.

The recommendations are published in the September/October issue of the journal Sports Health: A Multidisciplinary Approach.

"Ketorolac has been used most frequently as an analgesic pain reliever following strains, sprains and overuse injuries. Our recommendations on its use in NFL players hopefully will help minimize the risk of complications and allow for all parties involved in the health of athletes to better understand, how, when and why to use ketorolac more effectively and safely," lead author Dr. Matthew Matava, president-elect of the NFL Team Physicians Society, said in a journal news release.

The recommendations on ketorolac indicate:

  • It should be given only under the direct supervision and order of a team physician.
  • It should not be used before competition as a means of reducing anticipated pain.
  • It should only be used in players diagnosed with an injury or condition who are listed on the teams' latest injury report.
  • It should be given in the lowest effective therapeutic dose and for no more than five days.
  • It should be given by mouth under typical circumstances.
  • It should not be given by intramuscular and intravenous injection except following an acute, game-related injury where significant bleeding is not expected.
  • It should not be taken concurrently with other NSAIDs.

More information

The U.S. Food and Drug Administration offers a guide to the safe use of pain medicine.

-- Robert Preidt

SOURCE: Sports Health: A Multidisciplinary Approach, news release, Aug. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Precautions for tick-borne disease extend beyond Lyme
2. Use Caution When Exercising in Hot Weather
3. Supplements and cancer prevention: A cautionary tale
4. Penn study cautions use of drugs to block niacin flush
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NFL Docs Urge More Caution With Key Pain Med
(Date:1/15/2017)... ... 2017 , ... "On Tour is a music themed slideshow production package which ... Austin - CEO of Pixel Film Studios. , On Tour’s new slide presets ... animation of their slideshows. Place each slide on top of another slide or piece ...
(Date:1/14/2017)... MN (PRWEB) , ... January 14, 2017 , ... ... present the distinctions among their expanding line of activated charcoal products. With more ... the importance of categorizing their products according to how they cater to specific ...
(Date:1/13/2017)... ... ... The 18th European Congress: Perspectives in Lung Cancer will be held in ... is expertly designed to meet the educational needs of European oncology clinicians and researchers ... Dr. Giorgio V. Scagliotti, Professor of Oncology at the University of Torino, and organized ...
(Date:1/13/2017)... ... January 13, 2017 , ... An inventor from Virginia Beach, Va., is always ... order to diversify my outfits, so he decided to design something that enhances the ... the appearance of a belt to allow for quick, easy changing of its look. ...
(Date:1/13/2017)... , ... January 13, 2017 , ... MyGenetx, a molecular ... Communications, and Sales Administration Specialist, Mary Taylor Smith, RD, LD, will serve on the ... serving one year as a board member and one year as Vice President. She ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... 14, 2017  Johnson & Weaver, LLP announces that a ... Zimmer Biomet Holdings, Inc. (NYSE: ZBH )  securities ... 2016 (the "Class Period"). Zimmer Biomet provides musculoskeletal ... reconstructive products, such as knee and hip reconstructive products. ... According to ...
(Date:1/13/2017)... New York , January 13, 2017 ... rising prevalence of AIDS will collectively contribute to the demand ... expected to reach a value of US$ 551.0 Mn by ... will remain the most lucrative markets for western blotting, ... lead the market globally. ...
(Date:1/13/2017)... , January 13, 2017 This ... see how they have fared at yesterday,s closing bell: ... Biopharma Inc. (NASDAQ: GALE ), and ACADIA ... harness cellular and biomolecular processes to develop technologies and ... environmental footprint, feed the hungry, use less and cleaner ...
Breaking Medicine Technology: